查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1434124

自体免疫疾病治疗药物市场：依产品、应用分类 - 全球预测 2024-2030

Autoimmune Disease Therapeutics Market by Product (Diagnostic Equipment, Drugs), Application (Localized Autoimmune Diseases, Systemic Autoimmune Diseases) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年自体免疫疾病治疗市场规模为1,989.9亿美元，预计2024年将达2,145.4亿美元，2030年将达3,390亿美元，复合年增长率为7.90%。

自体免疫疾病药物的全球市场

主要市场统计
基准年[2023] 1989.9亿美元
预测年份 [2024] 2145.4亿美元
预测年份 [2030] 3390亿美元
复合年增长率（%） 7.90%
自体免疫疾病治疗市场-IMG1

FPNV定位矩阵

FPNV 定位矩阵对于评估自体免疫疾病治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对自体自体免疫疾病治疗药物市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-自体免疫疾病治疗药物市场的市场规模和预测是多少？

2-在自体自体免疫疾病治疗药物市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3-自体免疫疾病治疗药物市场的技术趋势和法律规范是什么？

4-自体自体免疫疾病治疗药物市场主要供应商的市场占有率是多少？

5-进入自体免疫疾病药物市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球自体免疫疾病的盛行率增加
      • 医疗基础设施的快速改善和患者意识层级的提高
      • 实验室自动化以促进一些自体免疫诊断测试
    • 抑制因素
      • 治疗费用高、治疗结果不确定
    • 机会
      • 增加政府机构和非营利组织的资金
      • 自体自体免疫疾病标靶治疗的出现
    • 任务
      • 自体自体免疫疾病免疫疗法的副作用
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章自体免疫疾病治疗药物市场：副产品

  • 诊断设备
  • 药物
    • 胺基或 5-ASA
    • 蒽甙
    • Avonex
    • Betaseron
    • 卡利泊三烯
    • 科帕松
    • 皮质类固醇
    • 糖皮质素
    • 羟氯喹
    • Methotrexate
    • 非类固醇消炎剂
    • Rebif

第七章自体免疫疾病治疗药物市场：依应用分类

  • 局部自体免疫疾病
  • 系统性自体免疫疾病

第八章北美和南美自体免疫疾病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区自体免疫疾病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲自体免疫疾病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca PLC
    • Beckman Coulter, Inc.
    • Bio-Rad Laboratories, Inc.
    • BioAgilytix Labs, LLC
    • bioMerieux SA
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Exagen, Inc.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services, Inc.
    • Lupin Limited
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.
    • Sanofi SA
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech PLC
    • UCB SA
    • Werfen SA
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-030C42D3EDB8

[197 Pages Report] The Autoimmune Disease Therapeutics Market size was estimated at USD 198.99 billion in 2023 and expected to reach USD 214.54 billion in 2024, at a CAGR 7.90% to reach USD 339.00 billion by 2030.

Global Autoimmune Disease Therapeutics Market

KEY MARKET STATISTICS
Base Year [2023] USD 198.99 billion
Estimated Year [2024] USD 214.54 billion
Forecast Year [2030] USD 339.00 billion
CAGR (%) 7.90%
Autoimmune Disease Therapeutics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autoimmune Disease Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autoimmune Disease Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autoimmune Disease Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMerieux S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Exagen, Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Lupin Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Sanofi S.A., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, UCB S.A., and Werfen S.A..

Market Segmentation & Coverage

This research report categorizes the Autoimmune Disease Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Diagnostic Equipment
    • Drugs
      • Aminosalicylates or 5-ASA
      • Anthralin
      • Avonex
      • Betaseron
      • Calicipotriene
      • Copaxone
      • Corticosteriods
      • Glucocorticoids
      • Hydroxychloroquine
      • Methotrexate
      • Non-steroidal Anti-inflammatory Drugs
      • Rebif
  • Application
    • Localized Autoimmune Diseases
    • Systemic Autoimmune Diseases
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Autoimmune Disease Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autoimmune Disease Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Autoimmune Disease Therapeutics Market?

4. What is the market share of the leading vendors in the Autoimmune Disease Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Autoimmune Disease Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Autoimmune Disease Therapeutics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of autoimmune diseases across the globe
      • 5.1.1.2. Rapidly improvement in healthcare infrastructure coupled with rising patient awareness levels
      • 5.1.1.3. Automation of laboratories to ease several autoimmune diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and uncertain outcomes of the treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing funding by government associations and non-profit organizations
      • 5.1.3.2. Emergence of target therapies for autoimmune disease
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects of autoimmune diseases immunotherapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Autoimmune Disease Therapeutics Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Equipment
  • 6.3. Drugs
    • 6.4.1. Aminosalicylates or 5-ASA
    • 6.4.2. Anthralin
    • 6.4.3. Avonex
    • 6.4.4. Betaseron
    • 6.4.5. Calicipotriene
    • 6.4.6. Copaxone
    • 6.4.7. Corticosteriods
    • 6.4.8. Glucocorticoids
    • 6.4.9. Hydroxychloroquine
    • 6.4.10. Methotrexate
    • 6.4.11. Non-steroidal Anti-inflammatory Drugs
    • 6.4.12. Rebif

7. Autoimmune Disease Therapeutics Market, by Application

  • 7.1. Introduction
  • 7.2. Localized Autoimmune Diseases
  • 7.3. Systemic Autoimmune Diseases

8. Americas Autoimmune Disease Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Autoimmune Disease Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Autoimmune Disease Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. AbbVie Inc.
    • 12.1.3. Amgen Inc.
    • 12.1.4. AstraZeneca PLC
    • 12.1.5. Beckman Coulter, Inc.
    • 12.1.6. Bio-Rad Laboratories, Inc.
    • 12.1.7. BioAgilytix Labs, LLC
    • 12.1.8. bioMerieux S.A.
    • 12.1.9. Bristol-Myers Squibb Company
    • 12.1.10. Eli Lilly and Company
    • 12.1.11. Exagen, Inc.
    • 12.1.12. F. Hoffmann-La Roche Ltd.
    • 12.1.13. GlaxoSmithKline PLC
    • 12.1.14. Johnson & Johnson Services, Inc.
    • 12.1.15. Lupin Limited
    • 12.1.16. Merck & Co., Inc.
    • 12.1.17. Novartis AG
    • 12.1.18. Pfizer, Inc.
    • 12.1.19. Sanofi S.A.
    • 12.1.20. Siemens Healthineers AG
    • 12.1.21. Thermo Fisher Scientific Inc.
    • 12.1.22. Trinity Biotech PLC
    • 12.1.23. UCB S.A.
    • 12.1.24. Werfen S.A.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. AUTOIMMUNE DISEASE THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AUTOIMMUNE DISEASE THERAPEUTICS MARKET DYNAMICS
  • FIGURE 7. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AUTOIMMUNE DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 9. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY AMINOSALICYLATES OR 5-ASA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY AVONEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY BETASERON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY CALICIPOTRIENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COPAXONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY CORTICOSTERIODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY GLUCOCORTICOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY HYDROXYCHLOROQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY REBIF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM AUTOIMMUNE DISEASE THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. AUTOIMMUNE DISEASE THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 152. AUTOIMMUNE DISEASE THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. AUTOIMMUNE DISEASE THERAPEUTICS MARKET LICENSE & PRICING